Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Advisory panel to the FDA unanimously recommends PDL's Zenapax

Oct. 20, 1997

VZV vaccines using gene product expressed during latency

Oct. 17, 1997

BioTransplant and Novartis expand xenotransplantation collaboration

Oct. 15, 1997

Magnetic protein conjugates from Behringwerke

Oct. 15, 1997

LXR files IDE with FDA for heart preservation solution

Oct. 14, 1997

Yoshitomi licenses immunosuppressant to Novartis

Oct. 13, 1997

Aviron updates vaccine clinical program

Oct. 10, 1997

Therapeutic Antibodies' CytoTAb enters clinical trials

Oct. 7, 1997

MOMP DNA immunization for chlamydial infections

Oct. 6, 1997

OraVax to market and distribute Evans Medical's yellow fever vaccine

Oct. 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...